<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33293837</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6973</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Infection and drug resistance</Title><ISOAbbreviation>Infect Drug Resist</ISOAbbreviation></Journal><ArticleTitle>Targeting Polyamine Metabolism for Control of Human Viral Diseases.</ArticleTitle><Pagination><StartPage>4335</StartPage><EndPage>4346</EndPage><MedlinePgn>4335-4346</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IDR.S262024</ELocationID><Abstract><AbstractText>A virus is an infectious particle which generally contains nucleic acid genome (DNA or RNA inside a protein shell), except for human immunodeficiency virus (HIV). Viruses have to reproduce by infecting their host cells. Polyamines are ubiquitous compounds in mammalian cells and play key roles in various cellular processes. The metabolic pathways of polyamines have been well studied. Targeting these metabolic pathways can reduce infections caused by viruses. In the study, we systematically reviewed the association of polyamine metabolic pathways and viruses including coxsackievirus B3 (CVB3), enterovirus 71 (EV71), poliovirus (PV), Zika virus (ZKV), hepatitis C virus (HCV), hepatitis B virus (HBV), dengue virus (DENV), Japanese encephalitis virus (JEV), yellow fever virus (YFV), Ebola virus (EBOV), marburgvirus (MARV), chikungunya virus (CHIKV), sindbis virus (SINV), Semliki Forest virus (SFV), Epstein-Barr virus (EBV), herpes simplex virus 1 (HSV), human cytomegalovirus (HCMV), vesicular stomatitis virus (VSV), Rabies virus (RABV), Rift Valley fever virus (RVFV), La Crosse virus (LACV), human immunodeficiency virus (HIV), Middle East respiratory syndrome virus (MERS-CoV), and coronavirus disease 2019 (SARS-CoV-2). This review revealed that targeting polyamine metabolic pathways may be a potential approach to control human viral infection.</AbstractText><CopyrightInformation>&#xa9; 2020 Huang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Mingyuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Weijian</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Haiyong</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4889-2752</Identifier><AffiliationInfo><Affiliation>School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Jincheng</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6196-3917</Identifier><AffiliationInfo><Affiliation>Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Medical Bioactive Molecular Research for Department of Education of Guangdong Province, Guangdong Medical University, Dongguan 523808, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center for Antitumor Active Substance Research and Development, Guangdong Medical University, Zhanjiang, Guangdong 524023, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Drug Resist</MedlineTA><NlmUniqueID>101550216</NlmUniqueID><ISSNLinking>1178-6973</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diseases</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">polyamine metabolism</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33293837</ArticleId><ArticleId IdType="pmc">PMC7718961</ArticleId><ArticleId IdType="doi">10.2147/IDR.S262024</ArticleId><ArticleId IdType="pii">262024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis BM, Rall GF, Schnell MJ. Everything you always wanted to know about rabies virus (but were afraid to ask). Annu Rev Virol. 2015;2(1):451&#x2013;471. doi:10.1146/annurev-virology-100114-055157</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-100114-055157</ArticleId><ArticleId IdType="pmc">PMC6842493</ArticleId><ArticleId IdType="pubmed">26958924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilliers K, Muller CJF, Page BJ. Human immunodeficiency virus in cadavers: a review. Clin Anat. 2019;32(4):603&#x2013;610. doi:10.1002/ca.23358</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ca.23358</ArticleId><ArticleId IdType="pubmed">30811656</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadav SS, Kumar A, Ahsan MJ, Jayaprakash V. Ebola virus: current and future perspectives. Infect Disord Drug Targets. 2015;15(1):20&#x2013;31. doi:10.2174/1871526515666150320162259</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871526515666150320162259</ArticleId><ArticleId IdType="pubmed">25910510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi C, Alsafi Z, O&#x2019;Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71&#x2013;76. doi:10.1016/j.ijsu.2020.02.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.02.034</ArticleId><ArticleId IdType="pmc">PMC7105032</ArticleId><ArticleId IdType="pubmed">32112977</ArticleId></ArticleIdList></Reference><Reference><Citation>Florin L, Lang T. Tetraspanin assemblies in virus infection. Front Immunol. 2018;9:1&#x2013;9. doi:10.3389/fimmu.2018.01140</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01140</ArticleId><ArticleId IdType="pmc">PMC5981178</ArticleId><ArticleId IdType="pubmed">29887866</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller-Fleming L, Olin-Sandoval V, Campbell K, Ralser M. Remaining mysteries of molecular biology: the role of polyamines in the cell. J Mol Biol. 2015;427(21):3389&#x2013;3406. doi:10.1016/j.jmb.2015.06.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.06.020</ArticleId><ArticleId IdType="pubmed">26156863</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi K, Kashiwagi K. Modulation of protein synthesis by polyamines. IUBMB Life. 2015;67(3):160&#x2013;169. doi:10.1002/iub.1363</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1363</ArticleId><ArticleId IdType="pubmed">25906835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesterberg RS, Cleveland JL, Epling-Burnette PK. Role of polyamines in immune cell functions. Med Sci (Basel). 2018;6(22):1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5872179</ArticleId><ArticleId IdType="pubmed">29517999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dever TE, Gutierrez E, Shin BS. The hypusine-containing translation factor eIF5A. Crit Rev Biochem Mol Biol. 2014;49(5):413&#x2013;425. doi:10.3109/10409238.2014.939608</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10409238.2014.939608</ArticleId><ArticleId IdType="pmc">PMC4183722</ArticleId><ArticleId IdType="pubmed">25029904</ArticleId></ArticleIdList></Reference><Reference><Citation>Puleston DJ, Buck MD, Klein Geltink RI, et al. Polyamines and eIF5A hypusination modulate mitochondrial respiration and macrophage activation. Cell Metab. 2019;30(2):352&#x2013;363.e358. doi:10.1016/j.cmet.2019.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC6688828</ArticleId><ArticleId IdType="pubmed">31130465</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Olsen ME, Vignuzzi M, Connor JH. Polyamines and their role in virus infection. Microbiol Mol Biol Rev. 2017;81(4):e00029&#x2013;00017. doi:10.1128/MMBR.00029-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00029-17</ArticleId><ArticleId IdType="pmc">PMC5706744</ArticleId><ArticleId IdType="pubmed">28904024</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivadeneyra L, Char&#xf3; N, Kviatcovsky D, et al. Role of neutrophils in CVB3 infection and viral myocarditis. J Mol Cell Cardiol. 2018;125:149&#x2013;161. doi:10.1016/j.yjmcc.2018.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2018.08.029</ArticleId><ArticleId IdType="pubmed">30393107</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z, Zhang Y, Huang K, et al. Two coxsackievirus B3 outbreaks associated with hand, foot, and mouth disease in China and the evolutionary history worldwide. BMC Infect Dis. 2019;19(1):1&#x2013;10. doi:10.1186/s12879-019-4107-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4107-z</ArticleId><ArticleId IdType="pmc">PMC6534883</ArticleId><ArticleId IdType="pubmed">31126252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicmal TM, Tate PM, Dial CN, et al. Polyamine depletion abrogates enterovirus cellular attachment. J Virol. 2019;1&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798109</ArticleId><ArticleId IdType="pubmed">31341056</ArticleId></ArticleIdList></Reference><Reference><Citation>Dial CN, Tate PM, Kicmal TM, Mounce BC. Coxsackievirus B3 responds to polyamine depletion via enhancement of 2A and 3C protease activity. Viruses. 2019;11(403):1&#x2013;15. doi:10.3390/v11050403</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11050403</ArticleId><ArticleId IdType="pmc">PMC6563312</ArticleId><ArticleId IdType="pubmed">31052199</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Cesaro T, Moratorio G, et al. Inhibition of polyamine biosynthesis is a broad-spectrum strategy against RNA viruses. J Virol. 2016;90(21):9683&#x2013;9692. doi:10.1128/JVI.01347-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-16</ArticleId><ArticleId IdType="pmc">PMC5068521</ArticleId><ArticleId IdType="pubmed">27535047</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Li R, Xie Z, et al. IL-6, IL-10 and IL-13 are associated with pathogenesis in children with enterovirus 71 infection. Int J Clin Exp Med. 2014;7(9):2718&#x2013;2723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4211780</ArticleId><ArticleId IdType="pubmed">25356130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Wang X, Zhou X, et al. Poliovirus detection and genetic characteristic from sewage in Heilongjiang province from 2013 to 2016. Jpn J Infect Dis. 2018;71(6):442&#x2013;447. doi:10.7883/yoken.JJID.2017.338</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2017.338</ArticleId><ArticleId IdType="pubmed">30068885</ArticleId></ArticleIdList></Reference><Reference><Citation>Musso D, DJ G. Zika virus. Clin Microbiol Rev. 2016;29(3):487&#x2013;524. doi:10.1128/CMR.00072-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00072-15</ArticleId><ArticleId IdType="pmc">PMC4861986</ArticleId><ArticleId IdType="pubmed">27029595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Poirier EZ, Passoni G, et al. Interferon-induced spermidine-spermine acetyltransferase and polyamine depletion restrict zika and chikungunya viruses. Cell Host Microbe. 2016;20(2):167&#x2013;177. doi:10.1016/j.chom.2016.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.06.011</ArticleId><ArticleId IdType="pubmed">27427208</ArticleId></ArticleIdList></Reference><Reference><Citation>Routhu NK, Xie Y, Dunworth M, et al. Polymeric prodrugs targeting polyamine metabolism inhibit zika virus replication. Mol Pharm. 2018;1&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538062</ArticleId><ArticleId IdType="pubmed">30040423</ArticleId></ArticleIdList></Reference><Reference><Citation>de Weerd NA, Vivian JP, Nguyen TK, et al. Structural basis of a unique interferon-&#x3b2; signaling axis mediated via the receptor IFNAR1. Nat Immunol. 2013;14(9):901&#x2013;907. doi:10.1038/ni.2667</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2667</ArticleId><ArticleId IdType="pubmed">23872679</ArticleId></ArticleIdList></Reference><Reference><Citation>Henig N, Avidan N, Mandel I, et al. Interferon-beta induces distinct gene expression response patterns in human monocytes versus T cells. PLoS One. 2013;8(4):e62366. doi:10.1371/journal.pone.0062366</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0062366</ArticleId><ArticleId IdType="pmc">PMC3633862</ArticleId><ArticleId IdType="pubmed">23626809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisel MB, Felmlee DJ, Baumert TF. Hepatitis C virus entry. Curr Top Microbiol Immunol. 2013;369:87&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463198</ArticleId></ArticleIdList></Reference><Reference><Citation>Korovina AN, Tunitskaya VL, Khomutov MA, et al. Biogenic polyamines spermine and spermidine activate RNA polymerase and inhibit RNA helicase of hepatitis C virus. Biochemistry. 2012;77(10):1413&#x2013;1422. doi:10.1134/S0006297912100094</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297912100094</ArticleId><ArticleId IdType="pubmed">23157297</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnova OA, Keinanen TA, Ivanova ON, et al. Hepatitis C virus alters metabolism of biogenic polyamines by affecting expression of key enzymes of their metabolism. Biochem Biophys Res Commun. 2017;483(2):904&#x2013;909. doi:10.1016/j.bbrc.2017.01.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.01.032</ArticleId><ArticleId IdType="pubmed">28082202</ArticleId></ArticleIdList></Reference><Reference><Citation>Masalova OV, Lesnova EI, Samokhvalov EI, et al. Low-molecular-weight regulators of biogenic polyamine metabolism affect cytokine production and expression of hepatitis &#x421; virus proteins in Huh7.5 human hepatocarcinoma cells. Mol Biol. 2017;51(3):453&#x2013;464. doi:10.1134/S0026893317030128</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0026893317030128</ArticleId><ArticleId IdType="pubmed">28707668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Tian Z. HBV-induced immune imbalance in the development of HCC. Front Immunol. 2019;10:2048. doi:10.3389/fimmu.2019.02048</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02048</ArticleId><ArticleId IdType="pmc">PMC6718466</ArticleId><ArticleId IdType="pubmed">31507621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao B, Wang Z, Pi S, et al. Difluoromethylornithine, a decarboxylase 1 inhibitor, suppresses hepatitis B virus replication by reducing hbc protein levels. Front Cell Infect Microbiol. 2020;10:158. doi:10.3389/fcimb.2020.00158</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00158</ArticleId><ArticleId IdType="pmc">PMC7176913</ArticleId><ArticleId IdType="pubmed">32373551</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller DA, Depelsenaire ACI, Young PR. Clinical and laboratory diagnosis of dengue virus infection. J Infect Dis. 2017;215(suppl_2):S89&#x2013;S95. doi:10.1093/infdis/jiw649</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw649</ArticleId><ArticleId IdType="pubmed">28403441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi B, Bragado L, Mammi P, et al. Dengue virus targets RBM10 deregulating host cell splicing and innate immune response. Nucleic Acids Res. 2020;48(12):6824&#x2013;6838. doi:10.1093/nar/gkaa340</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa340</ArticleId><ArticleId IdType="pmc">PMC7337517</ArticleId><ArticleId IdType="pubmed">32432721</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Li S-H, Zhu L, et al. Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability. Nat Commun. 2017;8(1):14. doi:10.1038/s41467-017-00024-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00024-6</ArticleId><ArticleId IdType="pmc">PMC5432033</ArticleId><ArticleId IdType="pubmed">28446752</ArticleId></ArticleIdList></Reference><Reference><Citation>Klitting R, Roth L, Rey FA, de Lamballerie X. Molecular determinants of yellow fever virus pathogenicity in Syrian golden hamsters: one mutation away from virulence. Emerg Microbes Infect. 2018;7(1):51. doi:10.1038/s41426-018-0053-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0053-x</ArticleId><ArticleId IdType="pmc">PMC5874243</ArticleId><ArticleId IdType="pubmed">29593212</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen ME, Filone CM, Rozelle D, et al. Polyamines and hypusination are required for ebolavirus gene expression and replication. mBio. 2016;7(4):e00882&#x2013;00816. doi:10.1128/mBio.00882-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00882-16</ArticleId><ArticleId IdType="pmc">PMC4981715</ArticleId><ArticleId IdType="pubmed">27460797</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen ME, Cressey TN, Muhlberger E, Connor JH. Differential mechanisms for the involvement of polyamines and hypusinated eif5a in ebola virus gene expression. J Virol. 2018;1&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158423</ArticleId><ArticleId IdType="pubmed">30045993</ArticleId></ArticleIdList></Reference><Reference><Citation>Amman BR, Nyakarahuka L, McElroy AK, et al. Marburgvirus resurgence in kitaka mine bat population after extermination attempts, Uganda. Emerg Infect Dis. 2014;20(10):1761&#x2013;1764. doi:10.3201/eid2010.140696</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2010.140696</ArticleId><ArticleId IdType="pmc">PMC4193183</ArticleId><ArticleId IdType="pubmed">25272104</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015;372(13):1231&#x2013;1239. doi:10.1056/NEJMra1406035</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1406035</ArticleId><ArticleId IdType="pubmed">25806915</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Wang M, Liao C, et al. Identification of aaNAT5b as a spermine N-acetyltransferase in the mosquito, Aedes aegypti. PLoS One. 2018;13(3):e0194499. doi:10.1371/journal.pone.0194499</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0194499</ArticleId><ArticleId IdType="pmc">PMC5858766</ArticleId><ArticleId IdType="pubmed">29554129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Cesaro T, Vlajni&#x107; L, et al. Chikungunya virus overcomes polyamine depletion by mutation of nsP1 and the opal stop codon to confer enhanced replication and fitness. J Virol. 2017;91(15):1&#x2013;45. doi:10.1128/JVI.00344-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00344-17</ArticleId><ArticleId IdType="pmc">PMC5512238</ArticleId><ArticleId IdType="pubmed">28539441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigei F, Nindo F, Mukunzi S, Ng&#x2019;ang&#x2019;a Z, Sang R. Evolutionary analyses of Sindbis virus strains isolated from mosquitoes in Kenya. Arch Virol. 2018;163(9):2465&#x2013;2469. doi:10.1007/s00705-018-3869-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-018-3869-8</ArticleId><ArticleId IdType="pubmed">29781064</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietil&#xe4; MK, Albulescu IC, MJv H, Ahola T. Polyprotein processing as a determinant for in vitro activity of semliki forest virus replicase. Viruses. 2017;9(10):292. doi:10.3390/v9100292</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9100292</ArticleId><ArticleId IdType="pmc">PMC5691643</ArticleId><ArticleId IdType="pubmed">28991178</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuomi K, Mantyjarvi R, Raina A. Inhibition of Semliki Forest and herpes simplex virus production in alpha-difluoromethylornithinetreated cells: reversal by polyamines. FEBS Lett. 1980;121(2):292&#x2013;294. doi:10.1016/0014-5793(80)80365-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(80)80365-6</ArticleId><ArticleId IdType="pubmed">6257550</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuomi K, Rainat A, Mantyjarvi R. Synthesis of Semliki-Forest virus in polyamine-depleted baby-hamster kidney cells. Biochem Soc. 1982;206:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1158556</ArticleId><ArticleId IdType="pubmed">6812570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowalk A, Green M. Epstein-barr virus. Microbiol Spectr. 2016;4(3):10.1128/microbiolspec.DMIH1122-0011-2015. doi:10.1128/microbiolspec.DMIH2-0011-2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.DMIH2-0011-2015</ArticleId><ArticleId IdType="pubmed">27337443</ArticleId></ArticleIdList></Reference><Reference><Citation>Casero RA Jr., Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov. 2007;6(5):373&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">17464296</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M, Gan Y-J, Davis TO, Scott RS. Downregulation of the polyamine regulator spermidine/spermine N1-acetyltransferase by epstein&#x2013;barr virus in a Burkitt&#x2019;s lymphoma cell line. Virus Res. 2013;177(1):11&#x2013;21. doi:10.1016/j.virusres.2013.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.07.004</ArticleId><ArticleId IdType="pmc">PMC3852694</ArticleId><ArticleId IdType="pubmed">23891576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumru OS, Joshi SB, Thapa P, et al. Characterization of an oncolytic herpes simplex virus drug candidate. J Pharm Sci. 2015;104(2):485&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">25362835</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson W, Roizman B. Compartmentalization of spermine and spermidine in the herpes simplex virion. Proc Nat Acad Sci USA. 1971;68(11):2818&#x2013;2821. doi:10.1073/pnas.68.11.2818</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.68.11.2818</ArticleId><ArticleId IdType="pmc">PMC389533</ArticleId><ArticleId IdType="pubmed">5288261</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohjanpelto P, Sekki A, Hukkanen V, Bonsdorff C-HV. Polyamine depletion of cells reduces the infectivity of herpes simplex virus but not the infectivity of virus. Life Sci. 1988;42(20):2011&#x2013;2018. doi:10.1016/0024-3205(88)90501-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(88)90501-2</ArticleId><ArticleId IdType="pubmed">2835567</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco A, Call&#xe9; A, Morfin F, et al. S-adenosyl methionine decarboxylase activity is required for the outcome of herpes simplex virus type 1 infection and represents a new potential therapeutic target. FASEB J. 2005;19(9):1128&#x2013;1130. doi:10.1096/fj.04-2108fje</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-2108fje</ArticleId><ArticleId IdType="pubmed">15863396</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y-L, Han -F-F, Gong -L-L, et al. Human cytomegalovirus infection and vascular disease risk: a meta-analysis. Virus Res. 2017;227:124&#x2013;134. doi:10.1016/j.virusres.2016.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.09.010</ArticleId><ArticleId IdType="pubmed">27664838</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyms AS, Williamson JD. Inhibitors of polyamine biosynthesis block human cytomegalovirus replication. Nature. 1982;297(5868):690&#x2013;691. doi:10.1038/297690a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/297690a0</ArticleId><ArticleId IdType="pubmed">6283366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson W, Breemen RV, Fields A, Lafemina R, Irmiere A. D,L-alpha-difluoromethylornithine inhibits human cytomegalovirus replication. J Virol. 1984;50(1):145&#x2013;154. doi:10.1128/JVI.50.1.145-154.1984</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.50.1.145-154.1984</ArticleId><ArticleId IdType="pmc">PMC255594</ArticleId><ArticleId IdType="pubmed">6321786</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez LL. Emergence and re-emergence of vesicular stomatitis in the United States. Virus Res. 2002;85(2):211&#x2013;219. doi:10.1016/S0168-1702(02)00026-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(02)00026-6</ArticleId><ArticleId IdType="pubmed">12034487</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa-Giron EP, Allen R, Sulkin SE. The infectivity and pathogenesis of rabiesvirus administered orally. Am J Epidemiol. 1970;91(2):203&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">4906507</ArticleId></ArticleIdList></Reference><Reference><Citation>Linthicum KJ, Britch SC, Anyamba A. Rift valley fever: an emerging mosquito-borne disease. Annu Rev Entomol. 2016;61(1):395&#x2013;415. doi:10.1146/annurev-ento-010715-023819</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-ento-010715-023819</ArticleId><ArticleId IdType="pubmed">26982443</ArticleId></ArticleIdList></Reference><Reference><Citation>McJunkin JE, Khan RR, Tsai TF. California-la crosse encephalitis. Infect Dis Clin North Am. 1998;12(1):83&#x2013;93. doi:10.1016/S0891-5520(05)70410-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5520(05)70410-4</ArticleId><ArticleId IdType="pubmed">9494831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrodomenico V, Esin JJ, Graham ML, et al. Polyamine depletion inhibits bunyavirus infection via generation of noninfectious interfering virions. J Virol. 2019;93(14):e00530&#x2013;00519. doi:10.1128/JVI.00530-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00530-19</ArticleId><ArticleId IdType="pmc">PMC6600196</ArticleId><ArticleId IdType="pubmed">31043534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrodomenico V, Esin J, Qazi S, et al. Virion-associated polyamines transmit with bunyaviruses to maintain infectivity and promote entry. ACS Infect Dis. 2020;6(9):2490&#x2013;2501. doi:10.1021/acsinfecdis.0c00402</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00402</ArticleId><ArticleId IdType="pubmed">32687697</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis DM, Archin NM, Latency P. Persistent human immunodeficiency virus infection, and the development of latency reversing agents. J Infect Dis. 2017;215(suppl_3):S111&#x2013;S118. doi:10.1093/infdis/jiw618</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw618</ArticleId><ArticleId IdType="pmc">PMC5410986</ArticleId><ArticleId IdType="pubmed">28520964</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevec D, Jaksche H, Oft M, et al. Inhibition of HIV-1 replication in lymphocytes by mutants of the rev cofactor eIF-5A. Science. 1996;271(5257):1858&#x2013;1860. doi:10.1126/science.271.5257.1858</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.271.5257.1858</ArticleId><ArticleId IdType="pubmed">8596953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque M, Hanauske-Abel HM, Palumbo P, et al. Inhibition of HIV-1 gene expression by ciclopirox and deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A. Retrovirology. 2009;6(1):90. doi:10.1186/1742-4690-6-90</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-6-90</ArticleId><ArticleId IdType="pmc">PMC2770518</ArticleId><ArticleId IdType="pubmed">19825182</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Henao-Mejia J, Liu H, Zhao Y, He JJ. Translational regulation of HIV-1 replication by HIV-1 rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3. J Neuroimmune Pharmacol. 2011;6(2):308&#x2013;321. doi:10.1007/s11481-011-9265-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-011-9265-8</ArticleId><ArticleId IdType="pubmed">21360055</ArticleId></ArticleIdList></Reference><Reference><Citation>Chafekar A, Fielding BC. MERS-CoV: understanding the latest human coronavirus threat. Viruses. 2018;10(2):93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5850400</ArticleId><ArticleId IdType="pubmed">29495250</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios Cruz M, Santos E, Vel&#xe1;zquez Cervantes MA, Le&#xf3;n Ju&#xe1;rez M. COVID-19, a worldwide public health emergency. Rev Clin Esp. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7173827</ArticleId><ArticleId IdType="pubmed">33998479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Lyudmila V, Borovikova HW, Metz C, Tracey KJ. Spermine inhibition of monocyte activation and inflammation. Mol Med. 1999;5(9):595&#x2013;605. doi:10.1007/BF03402072</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03402072</ArticleId><ArticleId IdType="pmc">PMC2230461</ArticleId><ArticleId IdType="pubmed">10551901</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>